It is planned to examine the effect of Vagus Nerve Stimulation on headache symptoms in individuals with tension-type headache.
Tension-type headache is the most common primary headache, usually bilateral, characterized by oppressive and squeezing pain of mild or moderate intensity, unchanged by physical activity. It affects approximately 80% of the population and has a point prevalence of 42% in the general population. There are various pharmacological and non-pharmacological treatment methods for tension-type headache. One of the non-pharmacological treatment methods may be Vagus Nerve Stimulation (VNS). VNS can affect healing processes by regulating the autonomic nervous system and reduce symptoms in tension-type headache.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
30
taVNS will be applied for a total of 12 sessions, 20 minutes each session, 3 days/week.
Bitlis Eren Üniversitesi
Bitlis, Turkey (Türkiye)
Pain intensity
In the headache diary, the severity of the pain will be questioned with a numerical pain scale.
Time frame: Change from baseline at 4 weeks
Pain duration
The duration of pain will be questioned in the headache diary.
Time frame: Change from baseline at 4 weeks
Number of days of pain for 1 month
The number of days of pain during a month will be questioned in the headache diary.
Time frame: Change from baseline at 4 weeks
Heart rate variability
Heart rate variability will be measured with an automatic device.
Time frame: Change from baseline at 4 weeks
Headache Impact Scale
It is a 6-item scale assessing vitality, pain, psychological state, social, role and cognitive function. The total score of the scale varies between 36-78; higher scores indicate a higher level of impact on the quality of life of the individual.
Time frame: Change from baseline at 4 weeks
Depression Anxiety Stress Scale (DASS-21)
It evaluates the condition of the individual in the last week. It is a 21-question questionnaire consisting of 3 subscales: depression, anxiety and stress. The questionnaire score ranges from 0 to 21 for each subgroup. High scores indicate the presence and severity of depression, anxiety and stress.
Time frame: Change from baseline at 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.